Krsnaa Diagnostics Limited Market Cap ($176.72 Million)
Market Cap & Net Worth: Krsnaa Diagnostics Limited (KRSNAA)
Krsnaa Diagnostics Limited market cap. Krsnaa Diagnostics Limited (NSE:KRSNAA) has a market capitalization of $176.72 Million (Rs16.34 Billion) as of November 1, 2026. Listed on the NSE stock exchange, this India-based company holds position #16825 globally and #863 in its home market, demonstrating a -2.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Krsnaa Diagnostics Limited's stock price Rs503.75 by its total outstanding shares 32438672 (32.44 Million). Also see Krsnaa Diagnostics Limited (KRSNAA) cash flow conversion for how efficiently the company converts equity into cash flow.
Krsnaa Diagnostics Limited Market Cap History (2021–2026)
Krsnaa Diagnostics Limited market cap history from 2021 to 2026. Data shows change from $255.56 Million to $176.72 Million (-11.91% CAGR). Check Krsnaa Diagnostics Limited (KRSNAA) share price today for real-time trading data and today's change.
Index Memberships
Krsnaa Diagnostics Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$139.63 Billion | 0.13% | #175 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.02 Trillion | 0.01% | #563 of 750 |
Weight: Krsnaa Diagnostics Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Krsnaa Diagnostics Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Krsnaa Diagnostics Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Krsnaa Diagnostics Limited growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
Krsnaa Diagnostics Limited's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.33x
Krsnaa Diagnostics Limited's market cap is 0.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $255.56 Million | $3.96 Billion | $1.85 Billion | 0.06x | 0.14x |
| 2022 | $160.50 Million | $4.55 Billion | $683.88 Million | 0.04x | 0.23x |
| 2023 | $246.88 Million | $4.87 Billion | $621.11 Million | 0.05x | 0.40x |
| 2024 | $310.64 Million | $6.20 Billion | $568.37 Million | 0.05x | 0.55x |
| 2025 | $253.06 Million | $7.17 Billion | $776.08 Million | 0.04x | 0.33x |
Competitor Companies of KRSNAA by Market Capitalization
Companies near Krsnaa Diagnostics Limited in the global market cap rankings as of November 1, 2026. Also see Krsnaa Diagnostics Limited balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Krsnaa Diagnostics Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Krsnaa Diagnostics Limited (2021–2026)
Market capitalization of Krsnaa Diagnostics Limited from 2021 to today. Between 2021 and today, Krsnaa Diagnostics Limited's market cap moved from $255.56 Million to $ 176.72 Million, with a yearly change of -11.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs176.72 Million | -30.17% |
| 2025 | Rs253.06 Million | -18.54% |
| 2024 | Rs310.64 Million | +25.83% |
| 2023 | Rs246.88 Million | +53.82% |
| 2022 | Rs160.50 Million | -37.20% |
| 2021 | Rs255.56 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Krsnaa Diagnostics Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $176.72 Million USD |
| MoneyControl | $176.72 Million USD |
| MarketWatch | $176.72 Million USD |
| marketcap.company | $176.72 Million USD |
| Reuters | $176.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more